Navigation Links
New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure
Date:11/5/2007

ORLANDO, Fla., Nov. 5 /PRNewswire-FirstCall/ -- New data from the CORONA study presented today at the American Heart Association 2007 Scientific Sessions showed that adding a statin to optimized heart failure treatment did not significantly improve the prognosis for patients with advanced heart failure because it could not reverse or prevent the deterioration of a failing heart.

Patients taking AstraZeneca's CRESTOR(R) (rosuvastatin calcium) 10 mg experienced an 8 percent reduction in the combined primary endpoint of cardiovascular death, myocardial infarction or stroke, which was not statistically significant (p=0.12). This reduction was primarily driven by a decrease in atherosclerotic events, i.e. stroke and myocardial infarctions (post hoc analysis, nominal p=0.05), where statins have been proven to have benefit. In this study the majority of deaths were due to sudden death, or non-ischemic causes, which did not appear to be impacted by statin therapy. In addition, significantly fewer hospitalizations occurred in patients on CRESTOR compared to placebo, whether due to any cause (p=0.007), cardiovascular causes (p<0.001), or for worsening heart failure (p=0.01).

"The CORONA results represent a major advancement in medical research and understanding of patients with advanced heart failure, as it appears they clearly differ from patients without heart failure in their response to statin treatment," said lead investigator Prof. John Kjekshus, Department of Cardiology, Rikshospitalet University Hospital, Oslo, Norway. "We added a highly effective statin on top of an optimal treatment regimen. Our findings suggest the major cause of death in these patients was likely not to be related to atherosclerotic events, where benefit with statins in non-heart failure patients has been demonstrated, but instead may have been caused by the deterioration of failing heart muscle damaged beyond repair. CORONA underscores the need for early intervention in the pro
'/>"/>

SOURCE AstraZeneca
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. AAHC Examines Nations Clinical Trials Infrastructure
2. Endoscopy Identified as Safe and Effective Method in Treating Common Complication of Gastric Bypass Surgery
3. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
4. DNA Test Predicts Harmful Effects of Cancer Drug
5. New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments
6. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
7. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
8. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
9. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA
10. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
11. New Topical Therapy Safely Treats Serious Skin Infections Without Systemic Side Effects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Gibraltar Associates, a leading public ... domestic communications and issues management, today announced ... PositiveID Corporation (Nasdaq: PSID ) to ... of record. Gibraltar Associates will conduct media ... the Company on its public relations programs. ...
(Date:12/14/2009)... -- Cardium Therapeutics (NYSE Amex: CXM ) ... GAM501 (Ad5PDGF-B/Collagen) in the Treatment of Diabetic Ulcers," ... Industry Conference held December 10-13, 2009 in St. ... attended by top industry leaders and renowned researchers ... Dr. Barbara K. Sosnowski, Cardium,s Vice President of ...
(Date:12/14/2009)... At GeoInvesting.com, we have been tracking Tianyin ... now. Our largest hang up had been with the ... June 2010 net income guidance of $11.3 million represents ... income of $7.9 million, the increase in shares poses ... which depends upon the share price and the Treasury ...
Breaking Medicine Technology:Gibraltar Associates Named Agency of Record for Health Information and Diagnostic Provider PositiveID Corporation 2Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 2Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 3Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 4GeoInvesting.com Offers Insight Into Two Growing Chinese Pharmaceutical Firms 2UCLA researchers engineer bacteria to turn carbon dioxide into liquid fuel 11099 1UCLA researchers engineer bacteria to turn carbon dioxide into liquid fuel 11099 2Princeton scientists find way to catalog all that goes wrong in a cancer cell 11094 1Princeton scientists find way to catalog all that goes wrong in a cancer cell 11094 2Canna can 3A Ornamental eliminates pollutants from stormwater runoff 11093 1Canna can 3A Ornamental eliminates pollutants from stormwater runoff 11093 2
(Date:12/14/2009)... 29,000 future cancers could be linked to scans performed in ... performed CT scans are exposing patients to far more radiation ... of thousands of cancers a year, two new studies claim. ... issue of the Archives of Internal Medicine , the ... F. Redberg, are calling on clinicians to limit radiation exposure ...
(Date:12/14/2009)... are linked to an increased risk of certain cancers. ... synthetic insulin preparation marketed under the trade name Lantus), ... cancers than other insulins or oral glucose lowering medications. ... important factors such as obesity that may have driven ... large randomized trial designed to examine another aspect of ...
(Date:12/14/2009)... meth and smoking, but concerns about prescription abuse, ... Fewer teenagers are using methamphetamine, but reductions in ... drugs remains high, U.S. health officials report. , ... as the hallucinogenic salvia leaf and the prescription ... attention-deficit hyperactivity disorder (ADHD), appear to be gaining ...
(Date:12/14/2009)... Urges Congress to Ensure Health Workforce Recommendations ... Congressional leaders must ensure that ... body with sufficient authority to ensure implementation ... policy, according to Dr. Steven A Wartman, ... Academic Health Centers (AAHC). "With each ...
(Date:12/14/2009)... Dec. 14 Following is a statement ... Kids: ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ) ,, The ... the National Institute of Drug Abuse shows that ... reducing youth smoking, but declines have slowed significantly ... decade. In especially troubling news, the survey ...
Breaking Medicine News(10 mins):Health News:Studies Quantify Cancer Risks From CT Scans 2Health News:Studies Quantify Cancer Risks From CT Scans 3Health News:Studies Quantify Cancer Risks From CT Scans 4Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 4Health News:Health Reform Needs Enforceable National Workforce Strategy 2Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 2Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 3Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 4Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 5
... known as scleroderma, is characterized by the formation of ... as the skin. Beyond its disfiguring symptoms, SSc is ... Pulmonary fibrosis strikes at least one-third of SSc sufferers, ... treating SSc remains challenging, despite recent clinical trials, due ...
... Teams Choose Best Plans for Their Brands, ... Qforma, an advanced analytics,company, today announced the ... This innovative new tool was developed to ... and,pull-through strategies. iQMCO(TM) utilizes advanced modeling techniques ...
... In a two-minute, forty-one second,video released today by ... in the nation executive weight loss,consulting service for ... Leventhal,Weight Loss Incorporated team physician both praise the ... on the company,s website:, http://www.attorneyweightloss.com ., "This ...
... Microflex Corporation (Reno, NV),a subsidiary of BarrierSafe ... new website designed by Project6, a San Francisco,Bay ... offers a fresh interface, significantly improved,navigation, and new ... right glove for their application., "It,s a ...
... to,the State of Iowa,s new smoke-free law, the American ... Tobacco-Free" conference on April,29th in Coralville, Iowa to assist ... will offer information on the new law,and feature speakers ... businesses that have questions about the law and the ...
... ROCKVILLE, Md., April 14 The United States,Pharmacopeial ... the Food,and Drug Administration (FDA) to develop more ... widely used blood-thinning,drug heparin. This contamination is suspected ... has resulted in over 60 deaths. The,suspected contaminant, ...
Other Medicine News:Health News:Study sheds light on deadly lung disease 2Health News:Study sheds light on deadly lung disease 3Health News:Qforma Unveils Managed Care Optimization Solution for Pharma Marketing Executives 2Health News:Client and Physician Praise Benefits of Leventhal Weight Loss Incorporated 2Health News:Microflex Corporation Launches New Website 2Health News:U.S. Pharmacopeia Aiding FDA in Improved Tests for Heparin Contamination 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: